A new class of drugs is saving the lives of children who once had no hope. These high-tech medicines can replace defective genes. But there’s a catch. Many cost millions of dollars for a single dose. And American health care hasn’t figured out how to pay. We wondered how medicine could be priced so high and how insurance plans could refuse a life saving treatment. So we asked the people you’re about to meet: a drug maker whose company charges three million for its medication, a CEO whose insurance plan won’t pay, and a mother named Ciji Green.
